Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism

BACKGROUND: Plasminogen activator inhibitor‐1 (PAI‐1), the main inhibitor of fibrinolysis, is frequently elevated in obesity and could potentially mediate the risk of venous thromboembolism (VTE) in obese subjects. However, whether PAI‐1 is associated with VTE remains uncertain. OBJECTIVE: To invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Frischmuth, Tobias, Hindberg, Kristian, Aukrust, Pål, Ueland, Thor, Brækkan, Sigrid K., Hansen, John‐Bjarne, Morelli, Vânia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314992/
https://www.ncbi.nlm.nih.gov/pubmed/35289062
http://dx.doi.org/10.1111/jth.15701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314992/
https://www.ncbi.nlm.nih.gov/pubmed/35289062
http://dx.doi.org/10.1111/jth.15701

Ejemplares similares